154 related articles for article (PubMed ID: 16703516)
1. Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy.
Zanchetta M; Walker S; Burighel N; Bellanova D; Rampon O; Giaquinto C; De Rossi A
J Infect Dis; 2006 Jun; 193(12):1718-27. PubMed ID: 16703516
[TBL] [Abstract][Full Text] [Related]
2. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
[TBL] [Abstract][Full Text] [Related]
3. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children.
Saitoh A; Hsia K; Fenton T; Powell CA; Christopherson C; Fletcher CV; Starr SE; Spector SA
J Infect Dis; 2002 May; 185(10):1409-16. PubMed ID: 11992275
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
Otero M; Nunnari G; Leto D; Sullivan J; Wang FX; Frank I; Xu Y; Patel C; Dornadula G; Kulkosky J; Pomerantz RJ
AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1097-103. PubMed ID: 14709246
[TBL] [Abstract][Full Text] [Related]
6. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
[TBL] [Abstract][Full Text] [Related]
7. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L
J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161
[TBL] [Abstract][Full Text] [Related]
8. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.
Saitoh A; Fenton T; Alvero C; Fletcher CV; Spector SA
Antimicrob Agents Chemother; 2007 Dec; 51(12):4236-42. PubMed ID: 17893156
[TBL] [Abstract][Full Text] [Related]
9. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
[TBL] [Abstract][Full Text] [Related]
10. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients.
Ibáñez A; Puig T; Elias J; Clotet B; Ruiz L; Martínez MA
AIDS; 1999 Jun; 13(9):1045-9. PubMed ID: 10397534
[TBL] [Abstract][Full Text] [Related]
11. Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection.
Yerly S; Perneger TV; Vora S; Hirschel B; Perrin L
AIDS; 2000 Dec; 14(18):2805-12. PubMed ID: 11153661
[TBL] [Abstract][Full Text] [Related]
12. Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy.
Saitoh A; Singh KK; Sandall S; Powell CA; Fenton T; Fletcher CV; Hsia K; Spector SA
J Allergy Clin Immunol; 2006 Apr; 117(4):909-15. PubMed ID: 16630951
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 DNA and RNA kinetics in primary HIV infection.
Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
Ghosn J; Pellegrin I; Goujard C; Deveau C; Viard JP; Galimand J; Harzic M; Tamalet C; Meyer L; Rouzioux C; Chaix ML;
AIDS; 2006 Jan; 20(2):159-70. PubMed ID: 16511408
[TBL] [Abstract][Full Text] [Related]
15. CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.
Li X; Margolick JB; Jamieson BD; Rinaldo CR; Phair JP; Jacobson LP
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):421-8. PubMed ID: 21602699
[TBL] [Abstract][Full Text] [Related]
16. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.
Hunt PW; Deeks SG; Rodriguez B; Valdez H; Shade SB; Abrams DI; Kitahata MM; Krone M; Neilands TB; Brand RJ; Lederman MM; Martin JN
AIDS; 2003 Sep; 17(13):1907-15. PubMed ID: 12960823
[TBL] [Abstract][Full Text] [Related]
17. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
18. Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy.
Riva E; Pistello M; Narciso P; D'Offizi G; Isola P; Galati V; Turriziani O; Tozzi V; Vincenzi L; Dianzani F; Antonelli G
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1599-604. PubMed ID: 11779347
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
[TBL] [Abstract][Full Text] [Related]
20. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections.
Nunnari G; Otero M; Dornadula G; Vanella M; Zhang H; Frank I; Pomerantz RJ
AIDS; 2002 Jan; 16(1):39-45. PubMed ID: 11741161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
